Vishal Dahya (M.D., ’14) was the lead author of a recent study that had encouraging results for HIV-positive people who’ve been getting long-term treatment.
The study, which Dahya presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy, was reported on the website TheBody.com. Researchers found that the HIV-positive people they studied — people on long-term antiretroviral therapy — had no higher calcium scores than the population as a whole. Those scores are related to calcium buildup in plaques, which is seen as evidence of coronary artery disease.
Dahya, a first-year resident in the FSU College of Medicine Internal Medicine Residency Program at Tallahassee Memorial Hospital, was also among HIV researchers interviewed by thebodypro.com on whether this had been a bad year for research on an HIV cure.
“Regardless of the diagnosis, regardless of disease, we have to stay positive in everything that we're doing,” Dahya replied. “Research has its downturns and upturns, but we have to be able to stay positive, because it's a process.
“Going back and trying to find the exact mechanisms that caused the relapses will definitely help prevent it from happening again, and also be able to further our research so we can get to that point in which we can find that cure.”